本页面由Tiger Trade Technology Pte. Ltd.提供服务

Elevance Health

317.13
-1.1000-0.35%
成交量:22.12万
成交额:6,995.77万
市值:699.92亿
市盈率:12.58
高:319.69
开:315.52
低:314.79
收:318.23
52周最高:444.37
52周最低:273.71
股本:2.21亿
流通股本:2.21亿
量比:0.32
换手率:0.10%
股息:6.84
股息率:2.16%
每股收益(TTM):25.21
每股收益(LYR):25.21
净资产收益率:13.25%
总资产收益率:4.35%
市净率:1.60
市盈率(LYR):12.58

数据加载中...

2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/20

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/15

重要事件披露

Form 8-K - Current report
2024/04/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/18

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/18

重要事件披露

Form 8-K - Current report
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/24

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/19

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]